Let-7a microRNA levels in KRAS-mutated colorectal carcinomas determine survival differences in patients treated with anti-EGFR. This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting I.
In many cancers, there exists a type of cancer cell called a cancer stem cell. These are cells that, after chemotherapy or immunotherapy, can cause recurrence of the disease. Glioblastomas, the most ...
3636 Background: Monoclonal antibodies against epidermal growth factor receptor (EGFR) such as cetuximab and panitumumab demonstrated efficacy in metastatic colorectal cancer patients (mCRC) without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback